NEW TREMFYA® (GUSELKUMAB) STUDY SHOWS CONSISTENT PERIANAL FISTULA REMISSION ACROSS KEY CROHN'S DISEASE PATIENT SUBGROUPS

Reuters · 2d ago

Please log in to view news